A novel efficient feeder-free culture system for the derivation of human induced pluripotent stem cells
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
In order to apply human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) to regenerative medicine, the cells should be produced under restricted conditions conforming to GMP guidelines. Since the conventional culture system has some issues that need to be addressed to achieve this goal, we developed a novel culture system. We found that recombinant laminin-511 E8 fragments are useful matrices for maintaining hESCs and hiPSCs when used in combination with a completely xeno-free (Xf) medium, StemFit™. Using this system, hESCs and hiPSCs can be easily and stably passaged by dissociating the cells into single cells for long periods, without any karyotype abnormalities. Human iPSCs could be generated under feeder-free (Ff) and Xf culture systems from human primary fibroblasts and blood cells, and they possessed differentiation abilities. These results indicate that hiPSCs can be generated and maintained under this novel Ff and Xf culture system.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The use of defined culture media with recombinant proteins instead of whole animal serum greatly increases process comparability and supply chain assurance [67,68,69].”
From Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies (2023) · cites this paper as [68]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Gene-modified therapies, including iPSC-derived products and CAR-T cells, present distinct biosafety and technical challenges for POC implementation (Nakagawa et al., 2014; Moradi et al., 2023).”
From Isolator-based point-of-care manufacturing: a practical solution for GMP-compliant cell and extracellular vesicles therapy production (2025) · cites this paper as Nakagawa et al., 2014
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
Self-citationInduction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Self-citationEmbryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Generation of germline-competent induced pluripotent stem cells
Okita, K., Ichisaka, T., & Yamanaka, S. (2007) · Nature · doi:10.1038/nature05934 · Cited by 4,299
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts
Nakagawa, M., Koyanagi, M., Tanabe, K., Takahashi, K., Ichisaka, T., Aoi, T., Okita, K., Mochiduki, Y., Takizawa, N., & Yamanaka, S. (2008) · Nature Biotechnology · doi:10.1038/nbt1374 · Cited by 2,380
A more efficient method to generate integration-free human iPS cells
Okita, K., Matsumura, Y., Sato, Y., Okada, A., Morizane, A., Okamoto, S., Hong, H., Nakagawa, M., Tanabe, K., Tezuka, K.-I., et al. (2011) · Nature Methods · doi:10.1038/nmeth.1591 · Cited by 2,061 · cited 3×
“Moreover, hiPSCs were successfully established from primary fibroblasts, peripheral blood and cord blood under these conditions using episomal vectors 16,17 .”
BackgroundMethodA ROCK inhibitor permits survival of dissociated human embryonic stem cells
Watanabe, K., Ueno, M., Kamiya, D., Nishiyama, A., Matsumura, M., Wataya, T., Takahashi, J. B., Nishikawa, S., Nishikawa, S.-I., Muguruma, K., et al. (2007) · Nature Biotechnology · doi:10.1038/nbt1310 · Cited by 2,055
Self-citationFeeder-free growth of undifferentiated human embryonic stem cells
Xu, C., Inokuma, M. S., Denham, J., Golds, K., Kundu, P., Gold, J. D., & Carpenter, M. K. (2001) · Nature Biotechnology · doi:10.1038/nbt1001-971 · Cited by 1,870
Chemically defined conditions for human iPSC derivation and culture
Chen, G., Gulbranson, D. R., Hou, Z., Bolin, J. M., Ruotti, V., Probasco, M. D., Smuga-Otto, K., Howden, S. E., Diol, N. R., Propson, N. E., et al. (2011) · Nature Methods · doi:10.1038/nmeth.1593 · Cited by 1,447 · cited 2×
“In addition, it is necessary to use defined culture system for the source of iPS cells, such as fibroblasts or blood cells 13,23 .”
BackgroundMethodEmbryonic stem cell trials for macular degeneration: a preliminary report
Schwartz, S. D., Hubschman, J.-P., Heilwell, G., Franco-Cardenas, V., Pan, C. K., Ostrick, R. M., Mickunas, E., Gay, R., Klimanskaya, I., & Lanza, R. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60028-2 · Cited by 1,409
Research works printed but not linked: 1
- Grigoriadis, A. E. et al. Directed differentiation of hematopoietic precursors and functional osteoclasts from human ES and iPS cells. Blood 115, 2769–2776 (2010). · DOI · Paper page
Cited by
Items 501–600 of 675
Kim, J., Baek, S., Hong, Y. J., de Paula, M. N., Prima, M. J., Oh, Y., Cha, S., Tae, J., Jang, Y. J., & Choe, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115954 · Cited by 2
“hFGF-2 promotes self-renewal and pluripotency and is an essential ingredient of many defined media including E8 for culturing hPSCs [3,18].”
BackgroundA Multilevel Approach to the Causes of Genetic Instability in Stem Cells
González, E. A. P. (2022) · Springer eBooks · doi:10.1007/978-981-16-6016-0_26-1 · Cited by 4
A Multilevel Approach to the Causes of Genetic Instability in Stem Cells
González, E. A. P. (2022) · Springer eBooks · doi:10.1007/978-981-19-2655-6_26 · Cited by 4
Kato, T., Nishimura, K., Hirao, M., Shimohama, S., & Takata, K. (2023) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12361 · Cited by 1
Emerging Stem Cell Therapy and Tissue Engineering-Based Approaches in Neurodegenerative Diseases
Khaboushan, A. S., Sadeghmousavi, S., & Kajbafzadeh, A. M. (2023) · Springer eBooks · doi:10.1007/978-981-99-0846-2_5-1 · Cited by 3
Nishimura, K., & Takahashi, J. B. (2016) · Advances in Regenerative Biology · doi:10.3402/arb.v3.31772 · Cited by 2
Stem Cell-based Therapy for Neurodegenerative Diseases
Takahashi, J. B. (2016) · Japanese Journal of Neurosurgery · doi:10.7887/jcns.25.985 · Cited by 2
Decellularized Extracellular Matrix for Stem Cell Culture
Hoshiba, T. (2021) · Springer eBooks · doi:10.1007/978-981-16-4420-7_17 · Cited by 2
Stem Cell Therapy for Parkinson's Disease
Han, F. (2016) · InTech eBooks · doi:10.5772/63340 · Cited by 2
“developed a new feeder‐free system to culture the hESCs and iPSCs in StemFitTM medium, which made a big step to make clinically applicable GMP‐standard cells [96].”
Ishikura, Y., & Saitou, M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64441-0 · Cited by 2
Sasaki‐Honda, M., Jonouchi, T., Arai, M., He, J., Okita, K., Sakurai, S., Yamamoto, T., & Sakurai, H. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.12.487997 · Cited by 4
Ichimura, T., Kakizuka, T., Sato, Y., Itano, K., Seiriki, K., Hashimoto, H., Itoga, H., Onami, S., & Nagai, T. (2024) · eLife · doi:10.7554/elife.93633.1 · Cited by 2
Ferreira, L. A., do Nascimento, D. F., Tandon, I., Cordes, L., & Balachandran, K. (2024) · Research Square · doi:10.1101/2024.06.20.599891 · Cited by 3
“While earlier studies have demonstrated that the fragment E8 of laminin-511 (LN511-E8) supports maintenance and differentiation of pluripotent stem cells in vitro [2,9,22,23], its use to reproduce methods validated using MG have not been explicitly addressed.”
BackgroundInfluentialGeometric inference of cross-species transcriptome correspondence
Tokuta, Y., Nakamura, T., Fujiwara, K., Imamura, M., Nagano, M., Saitou, M., Imoto, Y., & Hiraoka, Y. (2026) · Cell Reports Methods · doi:10.1101/2025.10.23.684069 · Cited by 2
In Vitro Niches for the Culture of Pluripotent Stem Cells
Ueki, M., & Ito, Y. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65534-4 · Cited by 1
Kamiya, D., Yamashita, T., Akaboshi, T., Yamaguchi, Y., Toyooka, Y., & Ikeya, M. (2022) · Stem Cell Research · doi:10.1016/j.scr.2022.102704 · Cited by 1
Differentiation of Human Fetal Muscle Stem Cells from Induced Pluripotent Stem Cells
Sato, M., Zhao, M., & Sakurai, H. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3036-5_11 · Cited by 1
Kim, M., Thanuthanakhun, N., & Kino‐oka, M. (2023) · Biotechnology Journal · doi:10.1002/biot.202300364 · Cited by 1
“[35,36] Briefly, each HA subcomponent was expressed separately in Escherichia coli and purified.”
BackgroundMethodPathological analysis of Prader-Willi syndrome using adipocytes
Kishimura, U., Soeda, S., Ito, D., Ueta, Y., Harada, M., Tanaka, M., & Taniura, H. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.150124 · Cited by 1
Takano, F., Kitamura, M., Ueda, K., & Nakamura, M. (2025) · American Journal Of Pathology · doi:10.1016/j.ajpath.2025.05.006 · Cited by 1
Development of a cell therapy set prototype for autologous iPS cells
Nakashima, Y., & Tsukahara, M. (2025) · Cytotherapy · doi:10.1016/j.jcyt.2025.07.004 · Cited by 2
Taniguchi, Y., Takizawa, M., Hada, A., Ishimaru, A., & Sekiguchi, K. (2025) · Matrix Biology · doi:10.1016/j.matbio.2025.10.003 · Cited by 1
Differentiation of iPS Cells into Periodontal Ligament Cells
Wu, Y., Iwasaki, K., Taniguchi, Y., Ishikawa, I., & Hashimoto, Y. (2025) · Tissue Engineering Part A · doi:10.1177/19373341251389015 · Cited by 1
Matsushita, T., Matsuyama, T., Kawasaki, T., & Uchiumi, F. (2025) · Organoids · doi:10.3390/organoids4040027 · Cited by 1
“The human iPSC line 1231A3 was established at and provided by the Center for iPS Cell Research and Application (CiRA), Kyoto University (Kyoto, Japan) [29].”
Kawamura, S., Yoneyama, Y., Saiki, N., Wu, Y., Moriya, C., Ohmura, R., Maezawa, M., Shimada, Y., Wang, Y., Mori, K., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102433 · Cited by 4
Mpox virus replicates in lung organoids without significantly affecting their cellular function
Nakata, Y., Uriu, K., Hashimoto, R., Yamamoto, T., Saito, A., Sato, K., & Takayama, K. (2025) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2025.102326 · Cited by 3
“The human iPS cell line, 1383D6 [16] (provided by Dr. Masato Nakagawa, Kyoto University), was maintained according to our previous report [11].”
Shimizu, E., Higa, M., Banno, K., Hibino, R., Ohno, F., Inagaki, A., & Tsukahara, M. (2026) · Cytotherapy · doi:10.1016/j.jcyt.2025.102040 · Cited by 1
Nagashima, T., Miki, K., Tsuchida, M., Whitehouse, J., Sasozaki, I. T., Higashiyama, Y., Ishida, H., Kashino, K., & Miyagawa, S. (2026) · Bioengineering & Translational Medicine · doi:10.1002/btm2.70108 · Cited by 2
Image-based epigenetic profiling with deep learning and high-speed super-resolution microscopy
Wang, Y., Ghani, N. S. A., Dutta, M., Adachi, S., Katoh, K., Namihira, M., Mitsuyama, T., & Saito, Y. (2026) · Epigenetics & Chromatin · doi:10.1186/s13072-026-00662-5 · Cited by 1
Continuous evolving humanoid for advanced cellular models
Shimojo, D., Qiu, S., Sasamata, M., Namatame, I., Yamagishi, Y., Matsukuma, K., Sasaki-Iwaoka, H., & Hirose, S.-I. (2026) · SLAS TECHNOLOGY · doi:10.1016/j.slast.2026.100407 · Cited by 2
Glycan-binding properties of SARS-CoV-2 spike proteins: interactions with aminoglycoside antibiotics
Hatakeyama, D., Shoji, M., Miki, Y., Ueki, S., Yamaguchi, K., Nakashima, K., Tanaka, Y., Yokogawa, M., Osawa, M., Kasai, Y., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-42404-3 · Cited by 1
“The procedures used in this study were modified from the previous report 36 .”
Okimura, K., Matsushita, T., Nakanishi, Y. Y., Yamamoto, T., Nishida, K. K., Nagai, K. K., Kanzaki, N., Hoshino, Y. Y., Uehara, K., Aoi, T., et al. (2026) · Regenerative Therapy · doi:10.1016/j.reth.2026.101107 · Cited by 1
“A dermal fibroblast-derived hiPSC line 409B2 [16] was transferred to feeder-and serum-free culture conditions [17] and maintained as previously described [18].”
Yoshikawa, H., Yoshida, E., 松本崇宏, Sugita, K., Kamiya, S., Ohgita, T., Kobuchi, S., Shimohama, S., & Takata, K. (2026) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2026.118664 · Cited by 1
Roles and therapeutic prospects of the laminin family in disorders of the nervous system
Zhang, X., Li, X., Gao, L., Qiao, Y., Lv, B., Zhang, Q. D., Zhang, M., Yu, J., Li, H., Bi, H., et al. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08410-9 · Cited by 2
“…and their E8 fragments (LN-511/521-E8) markedly enhance hPSC adhesion, survival, and single-cell passaging stability under xeno-free, chemically defined conditions, and have become main-stay GMP substrates; mechanistically, they promote survival via α6β1–Fyn–RhoA/ROCK signaling [115, 229, 393–395].”
Miura, A., Kobayashi, Y., Hirose, Y., Azuma, T., Shimbo, T., Ouchi, Y., Kitayama, T., Yamamoto, R., Takaki, E., Yamazaki, S., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-75278-0 · Cited by 1
From stem cells to somites: Revealing genetic and exogenous factors of human embryogenesis
Alejo-Vinogradova, M. T., Strøm, Y. E., Lamers, L. A., Chang, Y. W., Hendriksen, M. J., Moosajee, M., Vermeulen, M., & Stelloo, S. (2026) · Stem Cell Reports · doi:10.1016/j.stemcr.2026.103023 · Cited by 1
“To evaluate the impact of maintenance conditions on pluripotency and somitoid differentiation efficiency, human iPSCs were cultured in either mTeSR Plus or StemFit medium (Nakagawa et al., 2014) prior to differentiation.”
Kondo, T., Hidetaka, S., Watari, K., Taga, S., Sakakibara, M., Soen, M., Kawamoto, I., Nishida, K., Emoto, R., Shiraki, Y., et al. (2026) · Stem Cell Research & Therapy · doi:10.1186/s13287-026-05098-y · Cited by 1
“Feeder-free (Ff) hESCs were maintained on LM511-E8 matrix (Nippi, Tokyo, Japan) in StemFit medium (AK03; Ajinomoto, Tokyo, Japan) [8].”
Derivation of Induced Pluripotent Stem Cells
Healy, L. E., & Ruban, L. (2014) · Springer eBooks · doi:10.1007/978-1-4899-7507-2_9 · Cited by 1
Применение плюрипотентных стволовых клеток в медицине
Родин, С. А. (2015) · Research and Practical Medicine Journal · doi:10.17709/2409-2231-2015-2-2-44-52
“To date, methods of derivation, culturing and freezing/thawing under xeno-free (devoid of components of animal origin) and chemically defined conditions have been reported for hESCs [37–42] and hiPSCs [43, 44].”
MethodIschemic Stroke Pathophysiology and Cell Therapy
Ren, C., Han, R., Shi, J., & Ji, X. (2016) · Springer eBooks · doi:10.1007/978-981-10-2929-5_1 · Cited by 2
Establishment of DYT5 patient-specific induced pluripotent stem cells with a GCH1 mutation
Murakami, N., Ishikawa, T., Kondo, T., Imamura, K., Tsukita, K., Enami, T., Funayama, M., Shibukawa, R., Matsumoto, S., Izumi, Y., et al. (2017) · Stem Cell Research · doi:10.1016/j.scr.2017.07.029 · Cited by 1
“The generated iPSCs were grown under feeder-free conditions on laminin-511 E8 (Nippi, Tokyo, Japan)-coated plates with StemFit (AK02N or AK03N, Ajinomoto, Tokyo, Japan) (Nakagawa et al., 2014).”
MethodMesquita, F. C. P., Hochman‐Mendez, C., & Taylor, D. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822231-7.00001-1 · Cited by 2
Xeno-free cultivation of human induced pluripotent stem cells for clinical applications
Saleh, F., Mondeh-Lowor, R., & de Peppo, G. M. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85766-6.00001-2 · Cited by 1
Mondal, T., Konda, P. K., Das, K., Kumar, K., & Bag, S. (2022) · Indian Journal of Animal Research · doi:10.18805/ijar.b-4853 · Cited by 1
Ura, H., Togi, S., Hatanaka, H., & Niida, Y. (2022) · Stem Cell Research · doi:10.1016/j.scr.2022.102926 · Cited by 1
The adaptation of bovine embryonic stem cells to the changes of feeder layers
Xu, W., Gao, L., Li, W., Wang, J., Yue, Y., & Li, X. (2023) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-022-00731-5 · Cited by 1
“…embryonic stem cells (ESCs), induced pluripotent stem cells, and expanded potential stem cells (Evans and Kaufman 1981; Takahashi and Yamanaka 2006; Nakagawa et al. 2014; Yang et al. 2017; Kimura et al. 2018; Chen et al. 2019; Wang et al. 2020; Hayal and Doğan 2021; Soto et al. 2021; Zheng et al.…”
BackgroundFukusumi, H., Togo, K., Beck, G., Shofuda, T., Kanematsu, D., Yamamoto, A., Sumida, M., Baba, K., Mochizuki, H., & Kanemura, Y. (2023) · Stem Cell Research · doi:10.1016/j.scr.2023.103122 · Cited by 1
Nakamura, Y., Kobayashi, H. H., Fukuda, N., Tanaka, S., Murata, Y., Hatanaka, Y., Haketa, A., Tsunemi, A., Chen, L., & Abe, M. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09751-8 · Cited by 1
“The method for establishing iPSC from PBMCs is described in supplementary method ( Estab-lishment of iPSC from PBMCs of a patient ) in detail [1, 7, 8 ].”
Yoshida, T., Tsukamoto, M., Kimura, K., Tanaka, M., Kuwamura, M., & Hatoya, S. (2024) · Regenerative Therapy · doi:10.1016/j.reth.2024.11.010 · Cited by 1
van Sprang, J. F., Aarts, J. G. M., Arts, B., Brouns, J. E. P., Komil, M. I., Bartels, P. A. A., & Dankers, P. Y. W. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202404186 · Cited by 1
Non-viral derivation of induced pluripotent stem cells from the canine umbilical cord
Yamazaki, A., Shiozawa, S., Koushige, Y., Kondo, H., Shibuya, H., & EDAMURA, K. (2025) · PLoS ONE · doi:10.1371/journal.pone.0315161 · Cited by 1
Effect of iPS cell culture medium on the differentiation potential of induced cardiac tissues
Nakashima, Y., & Tsukahara, M. (2025) · Scientific Reports · doi:10.1038/s41598-025-13259-x · Cited by 4
“The StemFit AK03N medium without C medium has long been used to culture somatic cells prior to reprogramming 54 as well as for in vitro differentiation 38 .”
Thapa, S., Kim, J.-H., Jeong, J. Y., Hur, S. S., Lee, S. W., & Hwang, Y. (2025) · Cells · doi:10.3390/cells14181412 · Cited by 1
“Several studies have relied on adhesion-based purification and immunocytochemistry with epithelial markers, such as cytokeratin, to characterize VFE cells [4,37].”
Research on Skeletal Muscle Diseases Using Pluripotent Stem Cells
de Oñate, L., Garreta, E., Tarantino, C., Martínez, E., Capilla, E., Navarro, I., Gutiérrez, J., Samitier, J., Campistol, J. M., Muñoz‐Cánoves, P., et al. (2015) · InTech eBooks · doi:10.5772/60902 · Cited by 1
“These media include: TeSR2 [32], NutriStem [33], Essential E8 [24], and StemFit [34].”
BackgroundReconstitution of Germ Cell Development In Vitro
Yokobayashi, S., & Saitou, M. (2018) · Springer eBooks · doi:10.1007/978-981-10-7941-2_1 · Cited by 1
Ueda, M., Hashimoto, Y., Honda, Y., Baba, S., & Morita, S. (2018) · Medical Molecular Morphology · doi:10.1007/s00795-018-0211-1 · Cited by 1
A preview of selected articles
Atkinson, S. P. (2020) · Stem Cells Translational Medicine · doi:10.1002/sctm.20-0519 · Cited by 1
“for the chondrogenic potential of substrates composed of defined laminin fragments.(14,15) To explore this strategy further, researchers from the laboratory of Noriyuki Tsumaki (Kyoto University, Japan) analyzed the differential effects of culture sub-”
Substrates and Surfaces for Control of Pluripotent Stem Cell Fate and Function
Srinivasan, A., Toh, Y., Loh, X. J., Loh, X. J., Loh, X. J., Toh, W. S., & Toh, W. S. (2016) · Wiley eBooks · doi:10.1002/9781119242642.ch12 · Cited by 2
Vitillo, L., Durance, C., Hewitt, Z., Moore, H. D. M., Smith, A. G., & Vallier, L. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.04.22.043216 · Cited by 1
Stepwise in vitro induction of human somitic mesoderm and its derivativesPreprint
Yamanaka, Y., Uemura, M., & Alev, C. (2020) · doi:10.21203/rs.3.pex-827/v1 · Cited by 1
Atelocollagen is Promising for Three-Dimensional Culture of Human Induced Pluripotent Stem CellsPreprint
Nakashima, Y., & Tsukahara, M. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4076334 · Cited by 1
Stepwise in vitro induction of human somitic mesoderm and its derivativesPreprint
Alev, C., Yamanaka, Y., & Uemura, M. (2020) · doi:10.21203/rs.2.22919/v1 · Cited by 1
Yoneda, Y., Kato, H., Maezawa, Y., Yokote, K., & Nakanishi, M. (2024) · Biophysics and Physicobiology · doi:10.2142/biophysico.bppb-v21.s015 · Cited by 1
Modeling interregional propagation of α-synuclein in human striatal–midbrain assembloidsPreprint
Nishimura, K., Amimoto, N., Sato, Y., Morishima, M., Sakaibara, M., Haratake, A., Nakano, M., Kaneko, N., Yamamoto, H., Hirano‐Iwata, A., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.11.723670 · Cited by 1
Regenerating the brain: Stem cell differentiation and cholinergic dysfunction in Alzheimer disease
Malmsten, L. (2014) · Figshare
ПРИМЕНЕНИЕ ПЛЮРИПОТЕНТНЫХ СТВОЛОВЫХ КЛЕТОК В МЕДИЦИНЕ
Rodin, S., & Scheelesvag, S. (2015)
iPS Cell Therapy for Parkinson’s Disease
Takahashi, J. A. (2016) · Japanese Journal of Neurosurgery · doi:10.7887/jcns.25.489
Directing the Differentiation of Pluripotent Stem Cells to Renal End Points
Osafune, K. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800102-8.00035-7
New Trends in Clinical Applications of Induced Pluripotent Stem Cells
Pham, P. V., Phan, N. L.-C., Vu, N. B., Truong, N. H., & Phan, N. K. (2016) · Stem cells in clinical applications · doi:10.1007/978-3-319-40073-0_4 · Cited by 2
Lawford‐Smith, H. (2015)
Pluripotent Stem Cells and Skeletal Muscle Differentiation: Challenges and Immediate Applications
Garreta, E., Marco, A., Eguizábal, C., Tarantino, C., Samitier, M., Badiola-Mateos, M., Gutiérrez, J., Samitier, J., & Montserrat, N. (2017) · Springer eBooks · doi:10.1007/978-981-10-3292-9_1
Nishishita, N., Muramatsu, M., & Kawamata, S. (2015)
Yamamoto, M., Hiroyuki, T. O. D. A., & Tabata, Y. (2017) · KOBUNSHI RONBUNSHU · doi:10.1295/koron.2017-0067
Paes, B. C. M. F. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2019.tde-08012019-151743 · Cited by 1
Recent Advances in Stem Cell Therapy for Parkinson’s Disease
Choudry, U. K. (2020) · American Journal of Biomedical Science & Research · doi:10.34297/ajbsr.2020.07.001158 · Cited by 1
Pretemer, Y., Kawai, S., Watanabe, M., Nagata, S., Nishio, M., Tamaki, S., Alev, C., Xue, J., Wang, Z., Fukiage, K., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.05.19.103960
“The expression of chondrocyte markers and the change in chondrocyte morphology during HI were similar in the 1231A3 iPSC line (Nakagawa et al., 2014) (Figures S1A-S1F).”
BackgroundFutenma, T., Akiyama, Y., Tanaka, S., Honda, M. J., & Toriumi, T. (2021) · Journal of Hard Tissue Biology · doi:10.2485/jhtb.30.151
Induced pluripotent stem cells for modeling of Rett Syndrome
Shekhar, B. R., & Das, D. K. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85764-2.00014-4
Establishment of induced pluripotent stem cells from schizophrenia discordant fraternal twins
Yada, Y., Suga, M., Shibukawa, R., Sagara, Y., Okanishi, Y., Enami, T., Tsukita, K., Kondo, T., Imamura, K., Sugihara, G., et al. (2021) · Stem Cell Research · doi:10.1016/j.scr.2021.102504
MYCL promotes iPSC-like colony formation via MYC Box 0 and 2 domains
Akifuji, C., Iwasaki, M., Kawahara, Y., Sakurai, C., Cheng, Y., Imai, T., & Nakagawa, M. (2021) · doi:10.21203/rs.3.rs-817686/v1
A stress-reduced passaging technique improves the viability of human pluripotent cellsPreprint
Takahashi, K., Okubo, C., Nakamura, M., Iwasaki, M., Kawahara, Y., Tabata, T., Miyamoto, Y., Woltjen, K., & Yamanaka, S. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.12.464142
Hoshino, Y., & Matsushima, Y. (2020) · Nano biomedicine · doi:10.11344/nano.12.83
Inagaki, N. F., & Inagaki, F. F. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-85545-7.00001-6
Translational Research Methods: Renal Stem Cells
Osafune, K. (2014) · Springer eBooks · doi:10.1007/978-3-642-27843-3_16-1
A Previews of Selected Articles
Atkinson, S. P. (2021) · Stem Cells · doi:10.1002/stem.3458
Isacson, O., & Osborn, T. M. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.730362785.793554266
Ura, H., Togi, S., Iwata, Y., Ozaki, M., & Niida, Y. (2022) · Stem Cell Research · doi:10.1016/j.scr.2022.102860
Ura, H., Togi, S., Hatanaka, H., & Niida, Y. (2022) · Stem Cell Research · doi:10.1016/j.scr.2022.102885
Ura, H., Togi, S., Ozaki, M., Hatanaka, H., & Niida, Y. (2023) · Stem Cell Research · doi:10.1016/j.scr.2023.103075
Nakashima, Y., & Tsukahara, M. (2023) · Research Square · doi:10.21203/rs.3.rs-2811612/v1
Iwasaki, M., Drummond, N. J., McNay, D. E. G., Canham, M. A., Tikhomirov, D., Arafa, D., Lelos, M. J., Morizane, A., & Kunath, T. (2023) · Research Square · doi:10.21203/rs.3.rs-2996413/v1
Induced Pluripotent Stem Cells in Epithelial Lamellar Keratoplasty
Bojić, S., Figueiredo, F. C., & Lako, M. (2023) · Essentials in ophthalmology/Essentials ophthalmology · doi:10.1007/978-3-031-32408-6_16
HOIL-1L deficiency induces cell cycle alteration which causes immaturity of myocyte and fibrogenesisPreprint
Akagi, K., Baba, S., Fujita, H., Fuseya, Y., Yoshinaga, D., Kubota, H., Kume, E., Fukumura, F., Matsuda, K., Tanaka, T., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.29.560255
Induction of mesenchymal stem cell (MSC) differentiation from iPS cells using MSC medium
Yufan, W. U., Iwasaki, K., & Hashimoto, Y. (2023) · Dental Materials Journal · doi:10.4012/dmj.2023-130
Akagi, K., Baba, S., Fujita, H., Fuseya, Y., Yoshinaga, D., Kubota, H., Kume, E., Fukumura, F., Matsuda, K., Tanaka, T., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-57504-1
“Patient-specific (HOIL-1L_1, CiRA-j-0154B and HOIL-1L_2, CiRA-j-0154D) and healthy control hiPSCs (Control_1, CiRA-j-1616-A, Asian female volunteer) were established from the peripheral blood mononuclear cells (PBMCs) using episomal vectors containing reprograming factors 30 .”
Maruoka, A., Kimura, A., Hattori, F., Hitomi, H., Osafune, K., Shiojima, I., & Toyoda, N. (2024) · Research Square · doi:10.21203/rs.3.rs-4745956/v1
Emerging Stem Cell Therapy and Tissue Engineering-Based Approaches in Neurodegenerative Diseases
Khaboushan, A. S., Sadeghmousavi, S., & Kajbafzadeh, A. M. (2024) · Springer eBooks · doi:10.1007/978-981-99-7119-0_5
Kakizuka, T., Natsume, T., & Nagai, T. (2024) · Lab on a Chip · doi:10.1039/d4lc00528g · Cited by 2
Metadata
- Authors
- Nakagawa, M., Taniguchi, Y., Senda, S., Takizawa, N., Ichisaka, T., Asano, K., Morizane, A., Doi, D., Takahashi, J., Nishizawa, M., Yoshida, Y., Toyoda, T., Osafune, K., Sekiguchi, K., & Yamanaka, S.
- Affiliations
- Kyoto University (JP)
- Institute for Protein Research, The University of Osaka (JP)
- Ajinomoto (Japan) (JP)
- Gladstone Institutes (US)
- Corresponding author
- Nakagawa, Masato
- ORCID
- Venue
- Scientific Reports
- Published
- 2014-01-08
- Volume
- 4
- Issue
- 1
- Pages
- 3594-3594
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC3884228
- OpenAlex
- W1972564906
- Cited by
- 673
- References
- 30
- Citations by year
- 2026: 35 · 2025: 46 · 2024: 74 · 2023: 66 · 2022: 65 · 2021: 76 · 2020: 66 · 2019: 49 · 2018: 37 · 2017: 58 · 2016: 47 · 2015: 39 · 2014: 14
- FWCI
- 21.47
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/3.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/3.0/ (vor)
- Locations
- Scientific Reports (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion, cc-by-nc-nd)
- Institutional Repositories DataBase (IRDB) (submittedVersion)
- OUKA (Osaka University Knowledge Archive) (Osaka University) (submittedVersion)
- Kyoto University Research Information Repository (Kyoto University) (submittedVersion, cc-by-nc-nd)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Society for the Promotion of Science (25860747, 24790277, 24590353, 24592124, 25291026)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
- Keywords
- induced pluripotent stem cells, feeder-free culture, xeno-free culture, human embryonic stem cells, primary fibroblasts, blood cells, karyotype stability, cell dissociation, differentiation potential
- MeSH terms
- Cell Differentiation, Culture Media, Humans, Serial Passage, Cell Culture Techniques, Induced Pluripotent Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.